Point State Capital LP Horizon Therapeutics Public LTD CO Transaction History

Point State Capital LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$86.42 - $109.81 $2.16 Million - $2.75 Million	-25,000 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$98.56 - $119.91 $1.97 Million - $2.4 Million	-20,000 Reduced 44.44%	25,000 $2.69 Million
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $919,100 - $1.1 Million	-10,000 Reduced 18.18%	45,000 $4.93 Million
Q2 2021 Aug 13, 2021	BUY	$86.24 - $95.92 $4.74 Million - $5.28 Million	55,000 New	55,000 $5.15 Million
Q1 2021 May 14, 2021	SELL	$71.83 - $95.48 $1.89 Million - $2.51 Million	-26,250 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $1.76 Million - $2.22 Million	26,250 New	26,250 $1.92 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

Stay updated on Point State Capital LP with notifications on news.